[Skip to Content]
[Skip to Content Landing]
Article
November 1967

Pyridoxine-Responsive Sideroblastic Anemia Due to Antituberculous Drugs

Author Affiliations

Richmond, Va

From the Hematology Section, Veterans Administration Hospital and Medical College of Virginia, Richmond.

Arch Intern Med. 1967;120(5):602-606. doi:10.1001/archinte.1967.00300040086015
Abstract

SIDEROBLASTIC anemia responsive to pyridoxine hydrochloride has been reported to occur with isoniazid therapy.1,2 In view of the large number of patients receiving isoniazid, the incidence of this complication appears to be very low. Two other antituberculous drugs, cycloserine and pyrazinamide have also been associated in a few instances with development of sideroblastic anemia.3,4 It has been assumed that these drugs also induce some abnormality of pyridoxine metabolism and perhaps act synergistically with isoniazid in producing this picture, but pyridoxine has not been shown to produce any improvement in the anemia produced by this combination of drugs. In the one reported instance in which pyridoxine was administered, it was ineffective.4

In the case reported here, the picture of sideroblastic anemia developed soon after beginning cycloserine therapy for tuberculosis in a patient also receiving long-term isoniazid therapy. Pyridoxine produced a prompt response with return of hemoglobin to normal

First Page Preview View Large
First page PDF preview
First page PDF preview
×